Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer

  1. Peeters, M.
  2. Oliner, K.S.
  3. Price, T.J.
  4. Cervantes, A.
  5. Sobrero, A.F.
  6. Ducreux, M.
  7. Hotko, Y.
  8. André, T.
  9. Chan, E.
  10. Lordick, F.
  11. Punt, C.J.A.
  12. Strickland, A.H.
  13. Wilson, G.
  14. Ciuleanu, T.E.
  15. Roman, L.
  16. Van Cutsem, E.
  17. He, P.
  18. Yu, H.
  19. Koukakis, R.
  20. Terwey, J.-H.
  21. Jung, A.S.
  22. Sidhu, R.
  23. Patterson, S.D.
Revista:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Any de publicació: 2015

Volum: 21

Número: 24

Pàgines: 5469-5479

Tipus: Article

DOI: 10.1158/1078-0432.CCR-15-0526 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus